- NLNK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.0 million.
- NLNK has traded 50,038 shares today.
- NLNK is down 3.8% today.
- NLNK was up 9% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NLNK with the Ticky from Trade-Ideas. See the FREE profile for NLNK NOW at Trade-Ideas More details on NLNK: NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. Currently there are 3 analysts that rate NewLink Genetics a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for NewLink Genetics has been 360,400 shares per day over the past 30 days. NewLink has a market cap of $719.8 million and is part of the health care sector and drugs industry. The stock has a beta of -0.64 and a short float of 25.1% with 6.27 days to cover. Shares are up 27.8% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.